Giant Biogene Holding Future Growth
Future criteria checks 6/6
Giant Biogene Holding is forecast to grow earnings and revenue by 21.7% and 24.2% per annum respectively. EPS is expected to grow by 21.3% per annum. Return on equity is forecast to be 32.3% in 3 years.
Key information
21.7%
Earnings growth rate
21.3%
EPS growth rate
| Personal Products earnings growth | 16.6% |
| Revenue growth rate | 24.2% |
| Future return on equity | 32.3% |
| Analyst coverage | Good |
| Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17
Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,463 | 2,806 | 2,336 | N/A | 11 |
| 12/31/2025 | 5,990 | 2,275 | 1,884 | N/A | 13 |
| 12/31/2024 | 4,675 | 1,798 | 1,415 | N/A | 13 |
| 12/31/2023 | 3,524 | 1,452 | N/A | N/A | N/A |
| 6/30/2023 | 2,985 | 1,052 | 1,016 | 1,313 | N/A |
| 3/31/2023 | 2,675 | 874 | 897 | 1,122 | N/A |
| 12/31/2022 | 2,364 | 696 | 778 | 932 | N/A |
| 12/31/2021 | 1,552 | 809 | 617 | 692 | N/A |
| 12/31/2020 | 1,190 | 826 | 758 | 834 | N/A |
| 12/31/2019 | 957 | 552 | 571 | 656 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2367's forecast earnings growth (21.7% per year) is above the savings rate (2%).
Earnings vs Market: 2367's earnings (21.7% per year) are forecast to grow faster than the Hong Kong market (11.4% per year).
High Growth Earnings: 2367's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2367's revenue (24.2% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 2367's revenue (24.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2367's Return on Equity is forecast to be high in 3 years time (32.3%)